USFDA Closes Zydus Inspection with NAI

  Published 1 year ago

USFDA inspection (Mar 10-14, 2025) closed as NAI; Zydus Lifesciences continues global healthcare operations.

  • Inspection concluded with no regulatory action needed.
  • Zydus discovers, develops, and markets diverse therapies worldwide.
  • Closure confirms compliance and operational standards met.

You might like these

India Commits to Global Disaster Resilience

India's FY25 GDP Growth: A Mixed Picture

RBI Seeks to Align Call Rate with Policy Rate Amid Liquidity Moves

Shakti Pumps Wins Rs 114.58 Cr Solar Pumping Contract

Prostarm Info Systems IPO, Key Details

Boeing-GE Shares Drop Amid India Crash Safety Orders

Onix Solar Buys Stake in Onix-Tech Renewable for ₹4.89B

News that matters the most ⚡